Paper
0
SAT-371 No amino acid substitution in HBV PreS1, HDAg, or NTCP associated with suboptimal response to bulevirtide in combination with pegylated interferon alfa-2a treatment in participants with chronic hepatitis delta: results from MYR204 a phase 2b study
Authors
Jing Wang,Silvia Chang
Simin Xu,Ross Martin,Thomas Aeschbacher,Savrina Manhas,Roberto Mateo,Lindsey May,Dong Han,Tahmineh Yazdi,Caleb Marceau,Christopher Richards,Pui Ho,Chunfeng Li,C Martínez,Nadine Peinovich,Andrew Lopez,Dmitry Manuilov,Renée-Claude Mercier,Audrey Lau,Tarik Asselah,Fabien Zoulim,Evguenia Maiorova,Hongmei Mo
+22 authors
,Celia MartínezJournal
Published
Jun 1, 2024
Show more
Save
Tip0
TipSave
Abstract
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.